<< Back to Knowledge Hub

CD39+CD8+ T Cells as a Marker for Diagnosis and Prognosis of ESCC

A research group in China analyzed CD39+CD8+ T cells in esophageal squamous cell carcinoma. Based on mIF-stained samples acquired on the TissueFAXS platform, they propose these cells as new markers for diagnosis and prognosis.

oncology

biomarker discovery

immunophenotyping

Customer Publication

Dynamic Content Image

CD39+CD8+ T Cells as a Marker for Diagnosis and Prognosis of ESCC

15 Apr, 2025

LogoOrangewhite2025

TissueGnostics GmbH
Taborstraße 10/2/8
1020 Vienna, Austria
+43 1 216 11 90
This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact us

About Us

TissueGnostics provides advanced solutions for whole-slide imaging and image analysis in biological and clinical research. Our products help researchers to scan and analyze complex tissue samples, enabling more detailed insights into tissue structure, cellular interactions, and spatial cell landscape.

 

Keep in Touch

Be the first to hear about the latest scientific updates